Suppr超能文献

脑死亡供者肺脏处理方案:一项多中心研究。

Lung donor treatment protocol in brain dead-donors: A multicenter study.

机构信息

Service of Intensive Care, University Hospital Marqués de Valdecilla-IDIVAL, Santander.

Service of Intensive Care, University Hospital Virgen de las Nieves, Granada.

出版信息

J Heart Lung Transplant. 2015 Jun;34(6):773-80. doi: 10.1016/j.healun.2014.09.024. Epub 2014 Sep 28.

Abstract

BACKGROUND

The shortage of lung donors for transplantation is the main limitation among patients awaiting this type of surgery. We previously demonstrated that an intensive lung donor-treatment protocol succeeded in increasing the lung procurement rate. We aimed to validate our protocol for centers with or without lung transplant programs.

METHODS

A quasi-experimental study was performed to compare lung donor rate before (historical group, 2010 to 2012) and after (prospective group, 2013) the application of a lung management protocol for donors after brain death (DBDs) in six Spanish hospitals. Lung donor selection criteria remained unchanged in both periods. Outcome measures for lung recipients were early survival and primary graft dysfunction (PGD) rates.

RESULTS

A total of 618 DBDs were included: 453 in the control period and 165 in the protocol period. Donor baseline characteristics were similar in both periods. Lung donation rate in the prospective group was 27.3%, more than twice that of the historical group (13%; p < 0.001). The number of lungs retrieved, grafts transplanted, and transplants performed more than doubled over the study period. No differences in early recipients' survival between groups were observed (87.6% vs. 84.5%; p = 0.733) nor in the rate of PGD.

CONCLUSION

Implementing our intensive lung donor-treatment protocol increases lung procurement rates. This allows more lung transplants to be performed without detriment to either early survival or PGD rate.

摘要

背景

肺移植供体短缺是等待此类手术的患者的主要限制因素。我们之前的研究表明,强化肺供体处理方案成功提高了肺获取率。我们旨在验证该方案在有或没有肺移植项目的中心的有效性。

方法

进行了一项准实验研究,以比较 6 家西班牙医院在应用脑死亡(DBD)供体肺管理方案前后(历史组,2010 年至 2012 年;前瞻性组,2013 年)的肺供体率。两个时期的肺供体选择标准均保持不变。肺受体的结局指标为早期存活率和原发性移植物功能障碍(PGD)率。

结果

共纳入 618 例 DBD:对照组 453 例,方案组 165 例。两组供体基线特征相似。前瞻性组的肺捐献率为 27.3%,是历史组(13%;p < 0.001)的两倍多。研究期间,获取的肺数量、移植的移植物和进行的移植数量翻了一番多。两组间的早期受体存活率(87.6%比 84.5%;p = 0.733)或 PGD 率均无差异。

结论

实施我们的强化肺供体治疗方案可提高肺获取率。这使得可以进行更多的肺移植,而不会对早期存活率或 PGD 率造成不利影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验